Content by Keyword: Prescription Drugs

  • Home
  • Prescription Drugs
  • print
  • email
  • twitter
  • compact
Report page
Appendix D - Acronyms and Glossary

Performance Improvement 2009. Appendix D - Acronyms and Glossary

Acronyms and Glossary 1915(c) waivers  – refers to section 1915(c) of the Medicaid program allowing the Secretary of HHS to waive certain program requirements in the law. Waivers permit States greater flexibility to target program eligibility and provide home and community based services for the disabled and/or elderly population
Report page
What Accounts for Improper Medicaid Rebate

Performance Improvement 2009. What Accounts for Improper Medicaid Rebate Payments?

This study estimated inappropriate Medicaid rebate claims caused by unit of measure inconsistencies and determined how often States converted their Medicaid use data to correct for unit of measure inconsistencies. Prescription drugs are defined using two types of unit of measure standards. Inconsistencies between the two standards have potential
Report page
Do Average Sales Prices Exceed Average

Performance Improvement 2009. Do Average Sales Prices Exceed Average Manufacturer Prices for Specific Prescription Drugs?

Pursuant to Federal statute, the Office of Inspector General must notify the Secretary of the Department of Health and Human Services (the Secretary) if the average sales price (ASP) for a drug exceeds the drug’s average manufacturer price (AMP) by a threshold of 5 percent. If that threshold is met, the statute grants the Secretary auth
Report page
How Can We Improve Health Outcomes and Reduce

Performance Improvement 2009. How Can We Improve Health Outcomes and Reduce Medicare Expenditures for Certain Medicare Beneficiaries With Heart Problems?

The evaluation examined the impact of providing disease management services and a prescription drug benefit for Medicare fee-for-service beneficiaries with congestive heart failure, coronary artery disease or diabetes. Three disease management organizations participated in the demonstration. The evaluation used a randomized design where eligible
Report page
Do Nursing Homes Make Medicare Prescription Drugs

Performance Improvement 2009. Do Nursing Homes Make Medicare Prescription Drugs Available to Their Medicare-Medicaid Dual Eligible Residents?

This study provided an assessment of the availability of Medicare Part D prescription drugs to dual-eligible nursing home residents. It focused on issues that arose in the early stages of implementing the new benefit. The study was based on structured interviews with a sample of nursing home administrators, medical directors, and directors of ope
Report page
Appendix D - glossary of evaluation terms, terms-

Performance Improvement 2008. Appendix D - glossary of evaluation terms, terms-of-art used by some offices or agencies, and acronyms for the organizational units of HHS.

The glossary, new with this 2008 issue of the report, provides some assistance to readers who may be unfamiliar with the terms and acronyms found in the report. 1915(c) waivers – refers to section 1915(c) of the Medicaid program allowing the Secretary of HHS to waive certain program requirements in the law. Waivers permit States greater flexib
Report page
Appendix C - table of the studies in this report

Performance Improvement 2008. Appendix C - table of the studies in this report, organized by agency and office, indicating the Objective where the study may be found.

Elements of evaluation: Effective programs achieve results. Results derive from good management which requires good decisions. Good decision-making depends on good information. Good information requires good data and careful analysis. Creative project officers, skillful researchers, thoughtful and receptive leaders contribute to value-added e
Report page
Are Users of Online Toxicological Information

Performance Improvement 2008. Are Users of Online Toxicological Information Resources Satisfied?

A series of focus groups were conducted to solicit user feedback regarding five on-line Web resources that are part of a site known collectively as "TOXNET," maintained by the National Library of Medicine. All five resources provide information on toxic chemicals, environmental health, and related areas.
Report page
Do Average Sales Prices for Specific Prescription

Performance Improvement 2008. Do Average Sales Prices for Specific Prescription Drugs Exceed Average Manufacturer Prices?

This study examined whether the average sales prices (ASP) for individual Medicare Part B prescription drugs exceeded the average manufacturer prices (AMP) by at least five percent during the third quarter of 2006 and determined the impact of lowering reimbursement amounts for drugs that exceeded the five-percent threshold. Since January 2005, Med
Report page
How Much Did Medicaid Pay for Medical Services

Performance Improvement 2008. How Much Did Medicaid Pay for Medical Services and Prescription Drugs to Evacuees from Hurricanes Rita and Katrina?

This study examined Medicaid payments and services made for evacuees of Hurricanes Katrina and Rita for outpatient and medical services and for prescription drugs. It compared average Medicaid payments per evacuee to those per non-evacuee for medical services and prescription drugs. This provided an initial, aggregate-level analysis of medical ser
Report page
Does Payment Source Predict Skilled Nursing

Performance Improvement 2008. Does Payment Source Predict Skilled Nursing Facility and Nursing Home Resident Use of or Expenditures for Drugs?

Using the 2001 Medicare Current Beneficiary Survey and Medicare Part A skilled nursing facility claims, researchers compared use and spending for prescription and over the counter drugs during qualifying skilled nursing facility stays and for the longer term nursing home stays. Researchers compared drug utilization patterns between beneficiaries w
Report page
How Did Medicare Beneficiaries in Long-Term Care

Performance Improvement 2008. How Did Medicare Beneficiaries in Long-Term Care Facilities Use Drugs Compared to Community Residents Treated at the Same Time?

Researchers examined the drug use differences for Medicare beneficiaries depending on place of residence – in the community or in a long-term care facility. Differences existed in socio-demographic and drug utilization and costs by Medicare beneficiaries residing in long-term care facilities and those living in the community. Health status diffe
Report page
What Was National Drug Spending for Residents of

Performance Improvement 2008. What Was National Drug Spending for Residents of Long-Term Care Facilities, 1998-2001?

Researchers estimated the utilization pattern and expenditures for drug spending in long term care facilities by Medicare eligibility status and coverage source, as well as by type of facility. This was done using the 1998-2001 Medicare Current Beneficiary Survey Cost and Use Files.
Report page
How Do Medicare Beneficiaries Use of Medications

Performance Improvement 2008. How Do Medicare Beneficiaries Use of Medications in Long-Term Care Facilities Compare to Community Residents' Use Before the Addition of Medicare Drug Coverage?

This study prepared nationally-representative estimates of drug spending in long-term care facilities, compared drug use and spending for beneficiaries in long term care facilities versus beneficiaries in the community, and examined medication use and spending by short-stay skilled nursing home facility residents who transition into long term care
Report page
Goal 1 - IMPROVE THE SAFETY, QUALITY,

Performance Improvement 2008. Goal 1 - Improve the Safety, Quality, Affordability and Accessibility of Health CARE Including Behavioral Health CARE and Long Term CARE

IMPROVE THE SAFETY, QUALITY, AFFORDABILITY AND ACCESSIBILITY OF HEALTH CARE INCLUDING BEHAVIORAL HEALTH CARE AND LONG TERM CARE This Strategic Goal targets the need for people to be able to obtain and maintain affordable health care coverage, receive efficient high-quality health care services, and access appropriate information for informed
Report page
What Are Private Sector "Best Practice

Performance Improvement 2007. What Are Private Sector "Best Practice" Approaches to Control Costs of Prescription Drug Benefit Programs?

Summary:
Report page
What Is the Extent of Non-Medical Use of

Performance Improvement 2007. What Is the Extent of Non-Medical Use of Prescriptions Drugs in the United States?

Summary:
Report page
Office of the Assistant Secretary for Planning

Performance Improvement 2002. Office of the Assistant Secretary for Planning and Evaluation

Mission To provide analytical support and advice to the Secretary on policy development and assist the Secretary with the development and coordination of department wide program planning and evaluation activities. Evaluation Program
Report page
Healthcare/Public Health

Performance Improvement 2002. Healthcare/Public Health

Outstanding Evaluation Reforming Medicaid: The Experiences of Five Pioneering States with Mandatory Managed Care and Eligibility Expansions
Report
Performance Improvement 2002

Performance Improvement 2002

Performance Improvement 2002: Evaluation Activities of the U.S. Department of Health and Human Services is the eighth annual report to Congress summarizing previous fiscal year evaluation efforts. The purpose of this report is to provide Congress with outcome-oriented evaluation findings for the Department's programs, policies, and strategies. It

Pages

Form Approved OMB# 0990-0379 Exp. Date 9/30/2020